MX2019004116A - Metodo de preparacion de peptidos que comprenden una cadena lateral de lisina modificada lipofilicamente. - Google Patents

Metodo de preparacion de peptidos que comprenden una cadena lateral de lisina modificada lipofilicamente.

Info

Publication number
MX2019004116A
MX2019004116A MX2019004116A MX2019004116A MX2019004116A MX 2019004116 A MX2019004116 A MX 2019004116A MX 2019004116 A MX2019004116 A MX 2019004116A MX 2019004116 A MX2019004116 A MX 2019004116A MX 2019004116 A MX2019004116 A MX 2019004116A
Authority
MX
Mexico
Prior art keywords
side chain
lysine side
modified lysine
preparing peptides
lipophilically modified
Prior art date
Application number
MX2019004116A
Other languages
English (en)
Inventor
Henkel Bernd
PLEUSS Norbert
Ludwig Hoerlein Rolf-
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of MX2019004116A publication Critical patent/MX2019004116A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds
    • B01J2219/00725—Peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Water Supply & Treatment (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a un método de preparación de un péptido modificado en la cadena lateral de lisina por medio de síntesis de péptidos en fase sólida.
MX2019004116A 2016-10-10 2017-10-10 Metodo de preparacion de peptidos que comprenden una cadena lateral de lisina modificada lipofilicamente. MX2019004116A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16306332 2016-10-10
PCT/EP2017/075773 WO2018069295A1 (en) 2016-10-10 2017-10-10 Method of preparing peptides comprising a lipophilically modified lysine side chain

Publications (1)

Publication Number Publication Date
MX2019004116A true MX2019004116A (es) 2019-08-12

Family

ID=57153433

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019004116A MX2019004116A (es) 2016-10-10 2017-10-10 Metodo de preparacion de peptidos que comprenden una cadena lateral de lisina modificada lipofilicamente.

Country Status (15)

Country Link
US (1) US11021512B2 (es)
EP (1) EP3523324B1 (es)
JP (1) JP2019533666A (es)
KR (1) KR20190059321A (es)
CN (1) CN109790208A (es)
AR (1) AR109914A1 (es)
AU (1) AU2017341951B2 (es)
BR (1) BR112019007063A2 (es)
CA (1) CA3039752A1 (es)
IL (1) IL265888A (es)
MX (1) MX2019004116A (es)
RU (1) RU2755543C2 (es)
SG (1) SG11201903100TA (es)
TW (1) TW201821434A (es)
WO (1) WO2018069295A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020010715A (es) 2018-04-10 2021-01-08 Sanofi Aventis Deutschland Sintesis de lixisenatida con taponamiento.
WO2019197466A1 (en) 2018-04-10 2019-10-17 Sanofi-Aventis Deutschland Gmbh Method for cleavage of solid phase-bound peptides from the solid phase
CN110183531A (zh) * 2019-05-17 2019-08-30 河北常山生化药业股份有限公司 一种艾本那肽前体的制备方法
CN111704654B (zh) * 2020-06-18 2021-12-03 上海交通大学医学院附属仁济医院 肽类化合物及其制备方法与应用
WO2024156694A1 (en) 2023-01-24 2024-08-02 Boehringer Ingelheim International Gmbh Method for synthesizing polypeptides

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008023050A1 (en) * 2006-08-25 2008-02-28 Novo Nordisk A/S Acylated exendin-4 compounds
HUE037449T2 (hu) 2008-10-17 2018-08-28 Sanofi Aventis Deutschland Egy inzulin és egy GLP-1 agonista kombinációja
US8614182B2 (en) * 2009-07-30 2013-12-24 Jiangsu Hansoh Pharmaceuticals Co., Ltd. GLP-1 analogues and their pharmaceutical salts and uses
CN101987868B (zh) * 2009-07-30 2013-09-04 江苏豪森医药集团有限公司 Glp-1类似物的衍生物或其可药用盐和用途
FR2952695B1 (fr) 2009-11-13 2012-03-30 Commissariat Energie Atomique Reservoir de stockage d'hydrogene a hydrures metalliques
WO2011058082A1 (de) 2009-11-13 2011-05-19 Sanofi-Aventis Deutschland Gmbh Pharmazeutische zusammensetzung umfassend einen glp-1-agonisten und methionin
EP2539364A1 (en) * 2010-02-26 2013-01-02 Novo Nordisk A/S Peptides for treatment of obesity
CN107129538B (zh) * 2010-04-27 2021-07-16 西兰制药公司 Glp-1受体激动剂和胃泌素的肽缀合物及其用途
WO2013167454A1 (en) 2012-05-08 2013-11-14 Novo Nordisk A/S Double-acylated glp-1 derivatives
EA201590011A1 (ru) 2012-06-14 2015-05-29 Санофи Пептидные аналоги эксендина-4
UA116217C2 (uk) 2012-10-09 2018-02-26 Санофі Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону
CN104902920A (zh) 2012-12-21 2015-09-09 赛诺菲 作为glp1/gip双重激动剂或glp1/gip/胰高血糖素三重激动剂的毒蜥外泌肽-4衍生物
TW201625670A (zh) 2014-04-07 2016-07-16 賽諾菲公司 衍生自ｅｘｅｎｄｉｎ－４之雙重ｇｌｐ－１／升糖素受體促效劑
TW201625668A (zh) 2014-04-07 2016-07-16 賽諾菲公司 作為胜肽性雙重ｇｌｐ－１／昇糖素受體激動劑之艾塞那肽－４衍生物
TW201625669A (zh) * 2014-04-07 2016-07-16 賽諾菲公司 衍生自艾塞那肽－４（Ｅｘｅｎｄｉｎ－４）之肽類雙重ＧＬＰ－１／升糖素受體促效劑

Also Published As

Publication number Publication date
AR109914A1 (es) 2019-02-06
RU2019113729A3 (es) 2021-02-20
TW201821434A (zh) 2018-06-16
RU2755543C2 (ru) 2021-09-17
AU2017341951A1 (en) 2019-05-30
SG11201903100TA (en) 2019-05-30
CA3039752A1 (en) 2018-04-19
US11021512B2 (en) 2021-06-01
KR20190059321A (ko) 2019-05-30
EP3523324A1 (en) 2019-08-14
RU2019113729A (ru) 2020-11-13
WO2018069295A1 (en) 2018-04-19
EP3523324B1 (en) 2021-09-22
CN109790208A (zh) 2019-05-21
JP2019533666A (ja) 2019-11-21
BR112019007063A2 (pt) 2019-11-26
US20200024304A1 (en) 2020-01-23
IL265888A (en) 2019-06-30
AU2017341951B2 (en) 2021-08-05

Similar Documents

Publication Publication Date Title
MX2019004116A (es) Metodo de preparacion de peptidos que comprenden una cadena lateral de lisina modificada lipofilicamente.
MX2017006866A (es) Pares de unión para producción de péptidos.
EA201591995A1 (ru) Сконструированные полипептиды фенилаланин-аммиак-лиазы
PH12017500833A1 (en) Synthesis of copanlisib and its dihydrochloride salt
MX2019000664A (es) Preparacion de 14-metil-16-oxabiciclo[10.3.1]pentadecenos de 3-metil-1,5 ciclopentadecanediona.
MX2022013454A (es) Moduladores de la actividad del complemento.
MX2016000095A (es) Transtornos neurodegenerativos.
MX2017009595A (es) Compuestos antisenescentes y usos de los mismos.
MX2019007152A (es) Peptido novedoso.
JO3487B1 (ar) تخليق كوبانليسيب وملح الدايهيدروكلوريد الخاص به
EA033145B1 (ru) Применение полученных из pedf пептидов в стимуляции регенерации мышцы, регенерации сухожилия или артериогенеза
MX2019008241A (es) Un enlazador polipeptídico para preparar anticuerpos multispecíficos.
CL2017001310A1 (es) Péptidos cíclicos derivados de cd44v6 para el tratamiento de enfermedades relacionadas con cánceres y angiogénesis
MX2016014633A (es) Nuevos derivados de cath2.
IN2014DN09367A (es)
SG10201805039UA (en) Protease resistant peptides
MX2018014966A (es) Peptidos monolipidados resistentes a proteasas.
MX2015002279A (es) Peptido pntx(19) sintético, composición farmacéutica.y uso.
EP3574099C0 (en) PROMOTER CONSTRUCTION FOR CELLULAR PROTEIN SYNTHESIS
MX2020006758A (es) Cemento de alumina.
WO2012077037A3 (fr) Peptides modulateurs du complexe saspase-flg2
EA201691203A1 (ru) Твёрдые формы тенофовира
PH12020550538A1 (en) Method for the synthesis of cyclic depsipeptides
MX2020005454A (es) Tratamiento de cancer mejorado.
MX2020005884A (es) Procedimiento para la preparacion de carbodiimidas.